Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to (68)Ga-DOTATATE/-TOC uptake

BACKGROUND: The prognosis of patients with progressive meningioma after failure of surgery and radiotherapy is poor. METHODS: We retrospectively evaluated the safety and efficacy of somatostatin-receptor (SSTR)-targeted radionuclide therapy ((177)Lu-DOTATATE [n = 16], (90)Y-DOTATOC [n = 3], or both...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: Seystahl, Katharina, Stoecklein, Veit, Schüller, Ulrich, Rushing, Elisabeth, Nicolas, Guillaume, Schäfer, Niklaus, Ilhan, Harun, Pangalu, Athina, Weller, Michael, Tonn, Jörg-Christian, Sommerauer, Michael, Albert, Nathalie L.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
Clinical Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5063513/
https://ncbi.nlm.nih.gov/pubmed/27106404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now060
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items